SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/12/24 LifeStance Health Group, Inc. 8-K:5 3/12/24 8:138K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 34K 3: R1 Document And Entity Information HTML 47K 5: XML IDEA XML File -- Filing Summary XML 11K 8: XML XBRL Instance -- lfst-20240312_htm XML 15K 4: EXCEL IDEA Workbook of Financial Report Info XLSX 8K 2: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 72K Linkbases Document -- lfst-20240312 6: JSON XBRL Instance as JSON Data -- MetaLinks 11± 18K 7: ZIP XBRL Zipped Folder -- 0000950170-24-029684-xbrl Zip 9K
8-K |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i March 12, 2024 |
i LifeStance Health Group, Inc.
(Exact name of Registrant as Specified in Its Charter)
i Delaware |
i 86-1832801 |
|||
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
i 4800 N. Scottsdale Road i Suite 2500 |
|
|||
i Scottsdale, i Arizona |
|
i 85251 |
||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: i 602 i 767-2100 |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
i Common Stock, par value $0.01 per share |
|
i LFST |
|
i The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 12, 2024, the Company’s Board of Directors (the “Board”) appointed Teresa DeLuca as a director of the Company, effective immediately.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
LifeStance Health Group, Inc. |
|
|
|
|
Date: |
By: |
/s/ Ryan Pardo |
|
|
|
|
Name: Ryan Pardo |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 3/12/24 | None on these Dates | ||
List all Filings |